IREDA soars 5% after Rs 390-crore worth of shares change hands
IREDA has been included in the MSCI Small Cap index within three months of listing. The inclusion is expected to attract foreign inflows worth $17 million
Stay updated with breaking news from Uzzing Stocks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IREDA has been included in the MSCI Small Cap index within three months of listing. The inclusion is expected to attract foreign inflows worth $17 million
The pharma company's net profit declined 72 percent on year to Rs 46 crore. The bottomline also included exceptional expenses worth Rs 220 crore
The management says it expects growth to moderate in the coming quarter and in the financial year 2024-25. In the December quarter, the firm's consolidated net profit surged over 220 percent from the year-ago period
Nuvama Research has maintained buy rating on the stock but increased target price to Rs 561 from Rs 500 earlier, Motilal Oswal has retained its buy rating and increased target price to Rs 490 a share, up 13 percent.
According to the company, the Q3FY24 financials were impacted by significant losses incurred in select markets in US and Germany and both offices.